123 related articles for article (PubMed ID: 34083413)
1. Increased FNDC5/IRISIN protein expression in breast cancer tissue is associated with obesity in postmenopausal women.
Tejeda ME; Canto P; Tenorio-Torres A; Orozco-Arguelles L; Coral-Vázquez RM; Zentella-Dehesa A; Leal-García M; Vega-García CC; Bautista-Piña V; Méndez JP
J Clin Pathol; 2021 Jun; ():. PubMed ID: 34083413
[TBL] [Abstract][Full Text] [Related]
2. Expression of Irisin/FNDC5 in Breast Cancer.
Cebulski K; Nowińska K; Jablońska K; Romanowicz H; Smolarz B; Dzięgiel P; Podhorska-Okołów M
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408891
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin and adiponectin receptor 1 expression proteins levels are modified in breast cancer in postmenopausal women with obesity.
Orozco-Arguelles L; De Los Santos S; Tenorio-Torres A; Méndez JP; Leal-García M; Coral-Vázquez R; Vega-García C; Bautista-Piña V; Tejeda ME; Cárdenas-Cárdenas E; Canto P
J Clin Pathol; 2021 Sep; 74(9):571-576. PubMed ID: 32848015
[TBL] [Abstract][Full Text] [Related]
4. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.
Kurdiova T; Balaz M; Vician M; Maderova D; Vlcek M; Valkovic L; Srbecky M; Imrich R; Kyselovicova O; Belan V; Jelok I; Wolfrum C; Klimes I; Krssak M; Zemkova E; Gasperikova D; Ukropec J; Ukropcova B
J Physiol; 2014 Mar; 592(5):1091-107. PubMed ID: 24297848
[TBL] [Abstract][Full Text] [Related]
5. Auricular acupuncture induces FNDC5/irisin and attenuates obese inflammation in mice.
Lu Y; Li G
Acupunct Med; 2020 Aug; 38(4):264-271. PubMed ID: 32195595
[TBL] [Abstract][Full Text] [Related]
6. Icariin induces irisin/FNDC5 expression in C2C12 cells via the AMPK pathway.
Chen SQ; Ding LN; Zeng NX; Liu HM; Zheng SH; Xu JW; Li RM
Biomed Pharmacother; 2019 Jul; 115():108930. PubMed ID: 31055234
[TBL] [Abstract][Full Text] [Related]
7. The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer.
Cebulski K; Piotrowska A; Kmiecik A; Haczkiewicz-Leśniak K; Ciesielska U; Grzegrzółka J; Jabłońska K; Romanowicz H; Smolarz B; Dzięgiel P; Podhorska-Okołów M; Nowińska K
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239973
[TBL] [Abstract][Full Text] [Related]
8. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats.
Roberts MD; Bayless DS; Company JM; Jenkins NT; Padilla J; Childs TE; Martin JS; Dalbo VJ; Booth FW; Rector RS; Laughlin MH
Metabolism; 2013 Aug; 62(8):1052-6. PubMed ID: 23498898
[TBL] [Abstract][Full Text] [Related]
9. FNDC5 could be regulated by leptin in adipose tissue.
Gutierrez-Repiso C; Garcia-Serrano S; Rodriguez-Pacheco F; Garcia-Escobar E; Haro-Mora JJ; Garcia-Arnes J; Valdes S; Gonzalo M; Soriguer F; Moreno-Ruiz FJ; Rodriguez-Cañete A; Martinez-Ferriz A; Santoyo JS; Perez-Valero V; Garcia-Fuentes E
Eur J Clin Invest; 2014 Oct; 44(10):918-25. PubMed ID: 25112714
[TBL] [Abstract][Full Text] [Related]
10. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.
Moreno-Navarrete JM; Ortega F; Serrano M; Guerra E; Pardo G; Tinahones F; Ricart W; Fernández-Real JM
J Clin Endocrinol Metab; 2013 Apr; 98(4):E769-78. PubMed ID: 23436919
[TBL] [Abstract][Full Text] [Related]
11. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.
Huh JY; Panagiotou G; Mougios V; Brinkoetter M; Vamvini MT; Schneider BE; Mantzoros CS
Metabolism; 2012 Dec; 61(12):1725-38. PubMed ID: 23018146
[TBL] [Abstract][Full Text] [Related]
12. Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor?
Erickson HP
Adipocyte; 2013 Oct; 2(4):289-93. PubMed ID: 24052909
[TBL] [Abstract][Full Text] [Related]
13. The Effects of MiR-214-3p and Irisin/FNDC5 on the Biological Behavior of Osteosarcoma Cells.
Cheng G; Xu D; Chu K; Cao Z; Sun X; Yang Y
Cancer Biother Radiopharm; 2020 Mar; 35(2):92-100. PubMed ID: 32073886
[No Abstract] [Full Text] [Related]
14. Increased FNDC5/Irisin expression in human hepatocellular carcinoma.
Gaggini M; Cabiati M; Del Turco S; Navarra T; De Simone P; Filipponi F; Del Ry S; Gastaldelli A; Basta G
Peptides; 2017 Feb; 88():62-66. PubMed ID: 28012856
[TBL] [Abstract][Full Text] [Related]
15. Irisin ameliorates age-associated sarcopenia and metabolic dysfunction.
Guo M; Yao J; Li J; Zhang J; Wang D; Zuo H; Zhang Y; Xu B; Zhong Y; Shen F; Lu J; Ding S; Hu C; Xu L; Xiao J; Ma X
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):391-405. PubMed ID: 36510115
[TBL] [Abstract][Full Text] [Related]
16. Effects of Dietary Macronutrient Composition on FNDC5 and Irisin in Mice Skeletal Muscle.
de Macêdo SM; Lelis DF; Mendes KL; Fraga CAC; Brandi IV; Feltenberger JD; Farias LC; Guimarães ALS; de Paula AMB; Santos SHS
Metab Syndr Relat Disord; 2017 May; 15(4):161-169. PubMed ID: 28437200
[TBL] [Abstract][Full Text] [Related]
17. Irisin/FNDC5 inhibits the epithelial-mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway.
Zhu T; Zhang W; Zhang Y; Lu E; Liu H; Liu X; Yin S; Zhang P
Arch Gynecol Obstet; 2022 Sep; 306(3):841-850. PubMed ID: 35156135
[TBL] [Abstract][Full Text] [Related]
18. Significance of Irisin (FNDC5) Expression in Colorectal Cancer.
Wozniak S; Nowinska K; Chabowski M; Dziegiel P
In Vivo; 2022; 36(1):180-188. PubMed ID: 34972713
[TBL] [Abstract][Full Text] [Related]
19. FNDC5/Irisin protects neurons through Caspase3 and Bax pathways.
Zhang QX; Zhang LJ; Zhao N; Chang SH; Yang L
Cell Biochem Funct; 2024 Jan; 42(1):e3912. PubMed ID: 38269519
[TBL] [Abstract][Full Text] [Related]
20. Fndc5/irisin is regulated by myogenesis stage, irisin, muscle type and training.
Lavi G; Horwitz A; Einstein O; Zipori R; Gross O; Birk R
Am J Transl Res; 2022; 14(10):7063-7079. PubMed ID: 36398256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
